Retatrutide—A Game Changer in Obesity Pharmacotherapy

Retatrutide—A Game Changer in Obesity Pharmacotherapy

Obesity and type 2 diabetes mellitus (T2DM) are global health crises with significant morbidity and mortality. Retatrutide, a novel triple receptor agonist targeting glucagon-like peptide-1 (GLP-1), Glucose-Dependent Insulinotropic Polypeptide (GIP), and glucagon receptors, represents a groundbreaki...

Full description

Saved in:
Bibliographic Details
Main Authors: Vasiliki Katsi, Georgios Koutsopoulos, Christos Fragoulis, Kyriakos Dimitriadis, Konstantinos Tsioufis
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Biomolecules
Subjects:
retatrutide
obesity
incretins
type 2 diabetes mellitus
Online Access:https://www.mdpi.com/2218-273X/15/6/796
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items